GlassScriptPhysician profile
Claire D White
NPI 1568491884
$2,303.83
in general payments reported to CMS, 2019-2025
25 companies · $272 in 2025
The $272 reported for 2025 was more than what 82% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $328 · 2020: $306 · 2021: $406 · 2022: $434 · 2023: $379 · 2024: $180 · 2025: $272.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $830.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $829.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $367.82 | 2019-2024 | |
| Corium, LLC | $316.51 | 2021-2025 | Azstarys |
| Tris Pharma INC | $244.10 | 2019-2023 | Dyanavel Xr |
| Cranial Technologies, INC | $238.54 | 2019-2025 | Doc Band |
| Sanofi Pasteur INC. | $119.53 | 2021-2025 | |
| Sobi, INC | $109.52 | 2020-2023 | |
| Ironshore Pharmaceuticals INC. | $108.75 | 2019-2024 | Jornay Pm |
| Supernus Pharmaceuticals, INC. | $102.18 | 2021-2025 | Qelbree |
| Kaleo, INC. | $84.09 | 2022-2023 | Auvi-Q |
| Takeda Pharmaceuticals U.S.A., INC. | $83.60 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $68.63 | 2019-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Collegium Pharmaceutical, INC. | $63.16 | 2025 | Jornay Pm |
| Neos Therapeutics, LP | $61.05 | 2019-2022 | |
| Genentech USA, INC. | $50.76 | 2020-2022 | |
| Jazz Pharmaceuticals INC. | $43.65 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rhodes Pharmaceuticals L.P. | $43.15 | 2019 | |
| Ars Pharmaceuticals Operations, INC. | $39.00 | 2025 | Neffy |
| Dermira, INC. | $32.12 | 2020 | |
| Adlon Therapeutics L.P. | $25.47 | 2019-2020 | |
| Alexion Pharmaceuticals, INC. | $22.67 | 2025 | Strensiq |
| Seqirus USA INC | $21.93 | 2025 | Flucelvax |
| Biomarin Pharmaceutical INC. | $20.09 | 2024 | Voxzogo 1.2mg |
| Kowa Pharmaceuticals America, INC. | $13.38 | 2024 | Zoryve |
| Teva Pharmaceuticals USA, INC. | $13.30 | 2021 | |
| Glaxosmithkline, LLC. | $10.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Claire White listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.